← Back to Search

Electrophysiology Device

Optical Coherence Tomography (OCT) for Retinal Disease

N/A
Waitlist Available
Research Sponsored by Optos, PLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial is testing a new eye pressure-measuring device against a current one to see how well it works in normal, glaucoma, and retinal disease patients.

Eligible Conditions
  • Retinal Disease
  • Glaucoma
  • Normal

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Medical Devices
Limit of Agreement (LOA) between the P200TE and predicate device measurements of ganglion cell complex thickness (μm).
Optic Disk
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Optical Coherence Tomography (OCT)Experimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
P200TE
2019
N/A
~370
Predicate Device
2019
N/A
~300

Find a Location

Who is running the clinical trial?

Optos, PLCLead Sponsor
17 Previous Clinical Trials
3,500 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Apr 2025